Michele Maria Luchetti

Associate Professore Internal Medicine

Marche Polytechnic University

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Michele Maria Luchetti is an Associate Professor of Internal Medicine at Marche Polytechnic University in Italy. His research primarily focuses on inflammatory arthritis, with recent articles exploring topics such as the effectiveness of Upadacitinib and Secukinumab in various arthritis conditions, spondyloarthritis insights, and management of inflammatory bowel disease related to psoriatic arthritis. Dr. Luchetti's work emphasizes real-life clinical studies and treatment recommendations in the context of contemporary challenges in rheumatology.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (6)

Tim Raine

Cambridge University Hospitals NHS Foundation Trust

UNITED KINGDOM

View details

Danielle van der Windt

Professor of Primary Care Epidemiology

Keele University

UNITED KINGDOM

View details

Antonio Carletto

Professor of Practice

University of Verona

ITALY

View details

Arthur Kavanaugh

professor

University of California, San Diego

UNITED STATES

View details

Alen Zabotti

ITALY

View details

ANTONIO GIOVANNI SOLIMANDO

University of Bari Aldo Moro

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michele Maria Luchetti

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

The Challenge of IBD-Related Arthritis Screening Questionnaires in Early and Predominantly Entheseal Phenotypes

Clinical and Ultrasonographic Remission in Bio-naïve and Bio-failure Patients with Rheumatoid Arthritis at 24 Weeks of Upadacitinib Treatment: The UPARAREMUS Real-Life Study

Editorial: New insights into spondyloarthritis: from bench to bedside

Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort

Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis

The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients

Early administration of tofacitinib in COVID‐19 pneumonitis: An open randomised controlled trial

Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study

Management of Concomitant Inflammatory Bowel Disease or Uveitis in Patients With Psoriatic Arthritis: An Updated Review Informing the 2021 GRAPPA Treatment Recommendations

Editorial: Chronic autoimmune arthritis, infections and vaccines

Collaborators (6)

Tim Raine

Danielle van der Windt

Antonio Carletto

Arthur Kavanaugh

Alen Zabotti

ANTONIO GIOVANNI SOLIMANDO

Make your next move.